AebiS., GelberS., Castiglione-GertschM.: Is chemotherapy alone adequate for young women with oe-strogene-receptor-positive breast cancer?Lancet2000; 355: 1869–1874
2.
BerrutiA., ZolaP., BunivaT.: Endocrin therapy as maintenance therapy after first line epirubicin. Anticancer Res1997; 17(4A): 2763–2768.
3.
BursteinH.J., WinerE: Primary care for survivors of breast cancer. NEJM2000; 343: 1086.
4.
BuzdarAURole of aromatase inhibitors in advanced breast cancer. Endocr Relat Cancer1999; 6: 219–225.
5.
Del MastroL., VenturiniM., SertoliM.R.: Amenorrhea induced by adjuvant CT in early breast cancer patients. Prognostic role and clinical implication. Breast Cancer Res Treat1997; 43: 183–190.
6.
FisherB., DignamJ., WolmarkN.: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol1998; 16: 440–452.
7.
FisherB., DignamJ., WolmarkN.: Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet1999; 353: 1993–2000.
8.
ForwardD., CheungK.L., JacksonL.: Combined use of goserelin and anastrozole in premenopausal women with metastatic breast cancer. Proc ASCO2000; 19: a582
9.
FossatiR., ConfalonieriC., TorriV.: Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31510 women. J Clin Oncol1998; 16: 3439–3460.
10.
FossatiR., ConfalonieriC., TorriV.: Cytotoxic and hormonal treatment for metastatic breat cancer: a systematic review of published randomized trials involving 31510 women. J Clin Oncol1998; 16: 3439–3460.
11.
JulienJ.P., BijkerN., FentimanI.S.: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet2000; 355: 528–533.
12.
RobertsonJ., BuzdarA., NabholtzJ.: Anastrazole versus tamoxifene as a first-line therapy for advanced breast cancer in postmenopausal women. Prospective combined analysis from two international trials. EJC2000; 36(5): a219.
13.
The Consensus Conference Commitee, Consensus conference on the classification of ductal carcinoma in situ. Cancer1997; 80: 1798–1802.
